Biotech Archives - Pharmaphorum

Amgen invests £50m in UK genetics firm Oxford Nanopore

https://pharmaphorum.com/news/amgen-invests-50m-in-uk-genetics-firm-oxford-nanopore/

Crescendo hires ex-Roche R&D guru to develop T-cell technology

https://pharmaphorum.com/news/crescendo-hires-ex-roche-rd-guru-to-develop-t-cell-technology/

UK regenerative medicine biotech appoints veteran ‘drug hunter’ as CSO

https://pharmaphorum.com/r-d/oxstem-appoints-industry-vet-terstappen-as-cso/

Realising the biotech promise: addressing the path to market

https://pharmaphorum.com/market-access-2/addressing-the-path-to-market/

UK biotech investor Arix looks for new CEO

https://pharmaphorum.com/news/uk-biotech-investor-arix-looks-for-new-ceo/

Google Ventures leads $45.4m investment in UK exosome biotech Evox

https://pharmaphorum.com/news/google-ventures-leads-45-4m-investment-in-uk-exosome-biotech-evox/

Hong Kong biotechs IPOs face lower valuations after Ascletis flop

https://pharmaphorum.com/news/hong-kong-biotech-ipos-face-lower-valuations-after-ascletis-flop/

Novo acquires UK biotech Ziylo to develop “smart” insulin

https://pharmaphorum.com/news/novo-acquires-ziylo-smart-insulin/

Steve Paul reignites xanomeline research as Karuna CEO

https://pharmaphorum.com/news/steve-paul-reignites-xanomeline-research/

Search